Friday 6 November 2026 Export TEVA’s income statement to Excel — free account

Teva Pharmaceutical Industries Ltd.

TEVA Healthcare Drug Manufacturers Specialty & Generic

Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.

Revenue: −1.90%
EPS: −47.2%
Free cash flow: −30.3%
Total debt: −0.43%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

42.44 0.66 +1.58%

Follow TEVA

Alert me

Market cap: $48.7B
P/E: 92.6×
Fwd P/E: 30.7×
Dividend yield: —
F-score: 8/9
Altman Z: 0.79
Beneish M: −2.35
Dividend safety: 52/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	21.21%	21.58%	9.69%	6.65%
Piotroski F-Score Full definition →		8	7	7	6
ROA Full definition →		3.52%	3.99%	1.77%	1.27%
ROIC Full definition →		6.37%	6.77%	4.58%	4.09%
Return on Tangible Assets Full definition →		30.85%	37.48%	34.62%	17.34%
Average Days of Receivables Full definition →		78.44	71.38	73.63	81.28
Free Cash Flow per Share Full definition →		1.03	1.06	1.20	1.14
Free Cash Flow Full definition →		1,182.00	1,231.00	1,401.00	1,328.00
Capital Expenditures Full definition →		(467.00)	(483.00)	(497.00)	(442.00)
Other line items
Cash ROIC Full definition →		4.18%	4.30%	5.00%	4.61%
Accounts Receivable Turnover Full definition →		5.10	5.12	4.91	4.51
Accounts Payable Turnover Full definition →		3.52	3.40	3.15	3.27
Inventory Turnover Full definition →		2.69	2.59	2.45	2.47
Average Days of Payables Full definition →		111.04	113.93	120.65	116.23
Days of Inventory on Hand Full definition →		139.46	139.38	142.82	144.57
Tax Rate Full definition →		0.15	0.14	(0.02)	0.38
Research and Development Expense of Revenue Full definition →		5.87%	5.69%	9.90%	10.19%
Selling, General and Administrative Expense of Revenue Full definition →		23.02%	23.37%	23.85%	24.16%
Share Based Compensation of Revenue Full definition →		0.91%	0.96%	0.97%	1.00%
Operating CF/Net income Full definition →		1.17	1.10	2.68	3.49
Depreciation/Fixed assets Full definition →		0.25	0.25	0.25	0.26
Capex/Depreciation Full definition →		(0.47)	(0.48)	(0.50)	(0.45)
Revenue per Share Full definition →		15.07	15.01	14.86	14.78
Operating CF per Share Full definition →		1.44	1.48	1.63	1.52
Capex per Share Full definition →		(0.41)	(0.42)	(0.43)	(0.38)
Capex to Sales Full definition →		0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly